Study Of the Safety of Locally Manufactured 123I-metaiodobenzylguanidine(MIBG) in Routine Clinical Use
NCT01912040 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2022-11-14
Summary
Assessing 123 Iodine MIBG produced locally for safety while being used in clinical practice to help in patient management decisions.
Conditions
- Adrenergic Pathology
Interventions
- DRUG
-
Administration of 123Iodine MIBG
Patients will be administered the locally produced 123 Iodine MIBG
Sponsors & Collaborators
-
Nova Scotia Health Authority
lead OTHER
Principal Investigators
-
Andrew Ross, MD · Division Head, Nuclear Medicine
Eligibility
- Min Age
- 1 Month
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-07-31
- Primary Completion
- 2018-12-31
- Completion
- 2018-12-31
Countries
- Canada
Study Locations
More Related Trials
-
Clinical Trial of Dose-tolerance, Pharmacokinetics and Iodine Uptake For rhTSH In Post-thyroidectomized Patients
NCT04137185 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Prospective Study of Standard Treatment of Graves Disease Iodine 131 and Prevention of Adverse Reactions
NCT01204359 ·Status: UNKNOWN ·Phase: PHASE3
-
The Improvement of Intraoperative Neuromonitoring of Recurrent Laryngeal Nerve
NCT03911232 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
NCT07018323 ·Status: RECRUITING ·Phase: PHASE2
-
Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment
NCT06405217 ·Status: RECRUITING ·Phase: NA
-
Observation in the Treatment of Graves' Disease
NCT05043233 ·Status: UNKNOWN
-
Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter
NCT04856488 ·Status: RECRUITING ·Phase: PHASE3
-
Study for Treatment of Moderate or Severe, Periodic, "Cyclic", Breast Pain
NCT00237523 ·Status: UNKNOWN ·Phase: PHASE3
-
Desiccated Thyroid Extract and Levothyroxine for Hypothyroidism Treatment
NCT01739972 ·Status: UNKNOWN ·Phase: NA
-
Three-Year Follow-up of Radioiodine Therapy for Goitre
NCT00509483 ·Status: COMPLETED ·Phase: NA
-
Treatment of M.Graves With Radioactive Iodine: Follow-up Study
NCT00525122 ·Status: UNKNOWN
-
An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)
NCT01511393 ·Status: ENROLLING_BY_INVITATION
-
A Study of GensSci098 in Subjects With Graves' Disease
NCT07286656 ·Status: RECRUITING ·Phase: PHASE1
-
Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.
NCT00001730 ·Status: COMPLETED ·Phase: PHASE4
-
A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)
NCT07286006 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Iodinated Contrast Media Induced Hyperthyroidism
NCT04304794 ·Status: COMPLETED
-
Preoperative Preparation With Lugol Solution in Patients With Graves-Basedow Disease.
NCT03980132 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Liothyronine on Energy Expenditure and Cardiovascular Function
NCT03098433 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Radiofrequency Ablation for Amiodarone-induced Thyrotoxicosis
NCT03720210 ·Status: TERMINATED ·Phase: NA
-
Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules
NCT05142904 ·Status: TERMINATED ·Phase: PHASE3
-
Radioiodine Planar and a SPECT/CT Imaging With Iodine-123 for Evaluation of Follicular Thyroid Nodules Prior to Surgery
NCT05591092 ·Status: TERMINATED
-
Adequate Dosage of Sugammadex on Thyroid Surgery
NCT03689413 ·Status: COMPLETED ·Phase: NA
-
A Trial for the Evaluation of the Treatment and Outcome of Hyperthyroidism With Iodized Salt and Non Iodized Salt
NCT03444246 ·Status: UNKNOWN ·Phase: NA
-
Early Levothyroxine Post Radioactive Iodine
NCT01950260 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Dental Safety Profile of High-Dose Radioiodine Therapy
NCT00439478 ·Status: COMPLETED